Boston Scientific Expands Vascular Care Portfolio with $14.5bn Acquisition of Penumbra

Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn. The acquisition will expand Boston's offerings in vascular care space and bring in Penumbra's products, including Lightning Bolt and Lightning Flash computer-assisted vacuum thrombectomy systems. Boston expects to finance the $11bn cash portion of the transaction via a combination of cash on hand and new debt. The deal is expected to close in 2026.